Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients.
Journal: Leukemia & lymphoma
Published: May 18, 2026
SOHO State of the Art Updates and Next Questions: Is Combination Therapy Here for Myelofibrosis?
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 27, 2026
Progress of investigational bromodomain and extra-terminal domain inhibitors for myelofibrosis therapy.
Journal: Expert opinion on investigational drugs
Published: February 03, 2026
Interferon alpha in myeloproliferative neoplasms: evidence and practical considerations for clinical care.
Journal: Leukemia & lymphoma
Published: December 08, 2025
What are the future prospects for polycythemia vera pharmacotherapies for patients with hydroxyurea resistance?
Journal: Expert opinion on pharmacotherapy
Published: August 22, 2024
A novel application of XPO1 inhibition for the treatment of myelofibrosis.
Journal: Blood neoplasia
Published: February 23, 2024
Showing 1-7 of 7
Last Updated: 09/26/2026